Ovid Therapeutics Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Ovid Therapeutics Inc. (OVID) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-18
- Ovid Therapeutics Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.30%.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.20%.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.62%.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -2.25%, a 341.94% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.30% 10-K · filed 2026-03-18 | |
| 2024-12-31 | -0.20% 10-K · filed 2026-03-18 | -4.73% 10-K · filed 2025-03-11 |
| 2023-12-31 | -0.62% 10-K · filed 2025-03-11 | |
| 2022-12-31 | -2.25% 10-K · filed 2024-03-08 | |
| 2021-12-31 | 0.93% 10-K · filed 2023-03-13 | |
| 2020-12-31 | 0.02% 10-K · filed 2022-03-15 | |
| 2019-12-31 | -0.17% 10-K · filed 2021-03-15 | |
| 2018-12-31 | -0.04% 10-K · filed 2020-03-11 | |
| 2017-12-31 | -0.05% 10-K · filed 2019-03-07 | |
| 2016-12-31 | -0.19% 10-K · filed 2018-03-29 | |
| 2015-12-31 | 0.08% 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |